Protease inhibitors and beyond: interview with David Feigal, M.D. Interview by John S James.
Feigal
D
D
D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004345:Drug Industry; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D006297:Health Services Accessibility; D012367:RNA, Viral / Q000097:blood; D014481:United States; D014486:United States Food and Drug Administration; D014766:Viremia
D017320:HIV Protease Inhibitors; D012367:RNA, Viral